Opinion
When a group of companies conspires to fix prices at higher than a competitive level, the resulting overcharge is paid in the first instance by the direct purchaser of the cartel’s goods. In markets where the direct purchaser is not also the ultimate purchaser, but an intermediary between the cartel and the consumer (the indirect purchaser), several questions arise: First, who should be permitted to sue for price fixing, the direct purchaser, the indirect purchaser, or both? Second, how should damages be allocated? Should an antitrust conspirator be permitted to raise as a defense that the direct purchaser passed on some or all of the overcharge to indirect purchasers downstream in the chain of distribution?
Under federal antitrust law, the answer to these questions is settled. In
Hanover Shoe
v.
United Shoe Mach.
(1968)
Under state antitrust law, only the first question—who may sue—is settled. In 1978, in direct response to Illinois Brick, the Legislature amended the state’s Cartwright Act (Bus. & Prof. Code, § 16700 et seq.) 1 to provide that unlike federal law, state law permits indirect purchasers as well as direct purchasers to sue (§ 16750, subd. (a)). This left open the further question how damages should be allocated. Does the Cartwright Act permit a pass-on defense, or in this respect are state and federal law the same?
We conclude that under the Cartwright Act, as under federal law, generally no pass-on defense is permitted. While the text of the Cartwright Act does not answer the question, the Legislature’s actions in response to Illinois Brick and related federal statutory amendments reveal a clear legislative preference for the Hanover Shoe rule. As well, that rule is the one most closely in accord *764 with the Legislature’s overarching goals of maximizing effective deterrence of antitrust violations, enforcing the state’s antitrust laws against those violations that do occur, and ensuring disgorgement of any ill-gotten proceeds. Accordingly, we reverse the Court of Appeal, which held that a pass-on defense was available and that it entitled the alleged price-fixing defendants here to summary judgment.
Factual and Procedural Background
On appeal from a grant of summary judgment, we review and recite the evidence in the light most favorable to the nonmoving party (here, plaintiffs).
(Aguilar v. Atlantic Richfield Co.
(2001)
Plaintiffs (hereafter Pharmacies) are retail pharmacies located in California. 2 Defendants (hereafter Manufacturers) are, with two exceptions, companies that manufacture, market, and/or distribute brand-name pharmaceutical products throughout the United States. 3 Manufacturers also manufacture, market, and/or distribute similar brand-name pharmaceutical products in Canada where, unlike in the United States, the products are subject to government pricing restrictions.
Pharmacies filed suit under section 1 of the Cartwright Act (Stats. 1907, ch. 530, § 1, pp. 984-985, as amended; §§ 16720, 16726) and the unfair competition law (UCL) (§ 17200 et seq.), alleging Manufacturers had unlawfully conspired to fix the prices of their brand-name pharmaceuticals in the United States market, including in California. The complaint alleged *765 Manufacturers had agreed to set artificially high prices for their products, and had acted in concert to restrain reimportation of their lower priced foreign drugs into the United States and to restrict price competition from generics. As a result, the complaint alleged, Manufacturers were able to maintain prices for their drugs in California, as elsewhere in the United States, at levels 50 to 400 percent higher than for the same drugs sold outside the United States. Pharmacies alleged they consequently had been forced to pay an overcharge, the differential between the conspiracy-inflated prices set by Manufacturers and the prices Pharmacies would have paid in a competitive market. They sought treble damages, restitution, and injunctive relief.
Each Manufacturer answered, denying Pharmacies’ allegations and asserting as an affirmative defense that Pharmacies’ claims were barred on the ground Pharmacies passed on any alleged overcharge to third parties and therefore did not suffer a compensable injury.
Pharmacies filed a motion for summary adjudication of Manufacturers’ pass-on defense, arguing that the defense was unavailable under the Cartwright Act in light of
Hanover
Shoe, supra,
Evidence presented in connection with the cross-motions established the following essentially undisputed facts. Manufacturers sell their drugs to wholesalers at a price referred to as the wholesale acquisition cost. In turn, various independent entities use the wholesale acquisition cost to calculate and publish benchmark drug prices, termed the average wholesale price, for use in the industry. Wholesalers resell the drugs to Pharmacies at prices based on a percentage of the average wholesale price. Because the published average wholesale price is a fixed percentage above the price charged by Manufacturers to wholesalers, any price increases by Manufacturers will increase the average wholesale price proportionally. As a result, when Manufacturers increase their prices, the costs of drugs to Pharmacies increase by the same percentage amount.
In turn, Pharmacies sell the drugs to two groups of consumers: (1) those with third party insurance or a drug benefit plan offered by either a private entity or the government, which in turn pays customers’ claims on their behalf, and (2) uninsured (or cash-paying) consumers. For the first group, *766 those covered by third party payers, Pharmacies are reimbursed at a contractually or statutorily fixed amount, predetermined as a percentage of the average wholesale price, plus a dispensing fee; this reimbursement is greater than Pharmacies’ acquisition costs. For the second group, the cash-paying consumers, Pharmacies establish the retail prices unilaterally. Though not required to be, these prices traditionally have been based on a set percentage of the average wholesale price as well, plus in some instances an additional dispensing fee.
Currently, consumers covered by third party payers comprise the bulk of Pharmacies’ customers. It appears the percentage of cash-paying consumers has declined over time, with the consequence that the degree of price-setting discretion Pharmacies have has fallen as well.
In light of this evidence, the trial court granted Manufacturers’ summary judgment cross-motion and denied as moot Pharmacies’ summary adjudication motion. It held a pass-on defense was available under the Cartwright Act: A defendant could reduce or eliminate its liability upon proof that the plaintiff had passed on the alleged price overcharge and thereby limited its damages or suffered no injury. The trial court interpreted the evidence before it as showing that Pharmacies had passed on all of Manufacturers’ overcharges to consumers and had thus sustained no damages under the Cartwright Act. The pass-on defense similarly defeated Pharmacies’ UCL claim; the trial court concluded Pharmacies lacked standing to pursue the claim because, having recouped the overcharge, they had not “lost money or property,” as required under section 17204.
The Court of Appeal affirmed. It rejected the argument that the Legislature had approved application to the Cartwright Act of
Hanover Shoe, supra,
We granted review to address a significant issue of first impression: whether under the Cartwright Act an antitrust defendant can defeat liability by asserting a pass-on defense. (See
Global Minerals & Metals Corp. v. Superior Court
(2003)
Discussion
I. Hanover Shoe and Its Antecedents
In
Hanover Shoe, supra,
In a seven-to-one decision authored by Justice White, the United States Supreme Court rejected United Shoe’s assertion of a pass-on defense.
5
It held that “when a buyer shows that the price paid by him for materials purchased for use in his business is illegally high and ¿so shows the amount of the overcharge, he has made out a prima facie case of injury and damage within the meaning of § 4” of the Clayton Act (15 U.S.C. § 15).
(Hanover Shoe, supra,
Explaining this conclusion, the Supreme Court pointed out that however a buyer responds to illegal overcharges, he inevitably will be damaged. First, if the buyer does nothing and absorbs the loss, he suffers lost profits because, while revenue is static, his costs have been increased by the amount of the overcharge.
(Hanover Shoe, supra,
The Supreme Court offered two additional reasons why acceptance of the pass-on defense would be problematic. First, it would require a fact finder to decide a host of imponderables: whether in the absence of the illegal overcharge the plaintiff would have priced his product differently, what impact such a different price would have had on total sales “in the real economic world rather than an economist’s hypothetical model”
(Hanover Shoe, supra,
Second, broad acceptance of the defense would create a risk that no one would be left with a sufficiently significant injury to be motivated to seek relief; individual end consumers, each harmed to the tune of a few pennies or dollars only, might have insufficient motivation even to pursue a class action. Consequently, “those who violate the antitrust laws by price fixing or monopolizing would retain the fruits of their illegality because no one was available who would bring suit against them”
{Hanover Shoe, supra,
Hanover Shoe's
view of how properly to measure damages was not novel; as Justice White pointed out, a long line of Holmes and Brandéis opinions had adopted the same understanding. (See
Hanover Shoe, supra,
392 U.S. at pp. 489-490.) Writing for the court in
Chattanooga Foundry v. Atlanta
(1906)
This rejection of using overcharge pass-ons as a defense occurs not because the law is blind to their existence, but rather because its eyes are open to their ubiquity. Justice Holmes, again: The disregard of pass-ons is in part a recognition of “the endlessness and futility of the effort to follow every transaction to its ultimate result. [Citation.] Probably in the end the public pays the damages in most cases of compensated torts.”
(Southern Pac. Co. v. Darnell-Taenzer Co., supra,
With this background, we turn to the issue in this case. Does the rale of Hanover Shoe, that a defensive pass-on theory may not be used to defeat an antitrust damages claim, apply under the Cartwright Act?
II. The Cartwright Act and the Pass-on Defense
A. The Cartwright Act’s Text and Early History
We begin with the language of the statute. If the text is sufficiently clear to offer conclusive evidence of the statute’s meaning, we need look no further.
(Microsoft Corp. v. Franchise Tax Bd.
(2006)
Section 16750, subdivision (a) authorizes anyone “injured in his or her business or property” by actions forbidden under the Cartwright Act (§ 16700 et seq.) to recover three times the “damages sustained.” Aside from an increase in the multiplier, to treble damages from the original double damages, this language has been carried forward essentially without change from the original version of the act. 7
*771
We reject at the outset Manufacturers’ contention that the choice of the words “damages sustained” (§ 16750, subd. (a)) or “damages by him sustained” (Stats. 1907, ch. 530, § 11, p. 987) establishes a particular legislative intent on the question whether a pass-on defense should be available. The express text says only that a party must have been “injured” by a Cartwright Act violation and may recover the resulting “damages sustained”; it says nothing about how the injury or damages are to be quantified. In the antitrust context, one might measure the damages from a violation any number of ways: e.g., the excess amount a party paid the violator (the overcharge) (see
Hanover Shoe, supra,
392 U.S. at pp. 487-490); the sales a party lost as a result of the overcharge (lost sales) (see
Hanover Shoe,
at p. 493;
Kansas
v.
UtiliCorp United Inc.
(1990)
That the text of the Cartwright Act is ambiguous on this point is further illustrated by the fact the United States Supreme Court, interpreting the essentially identical language of the federal Clayton Act (15 U.S.C. § 12 et seq.), reached a conclusion diametrically opposite to that of the Court of Appeal in this case. Construing the Clayton Act’s damages provision (“damages by him sustained”), 8 the Supreme Court concluded defensive use of a pass-on theory was prohibited (Hanover Shoe, supra, 392 U.S. at pp. 489^494); construing the Cartwright Act’s damages provision (“damages sustained”), 9 the Court of Appeal here concluded such use of a pass-on theory was permitted, indeed compelled. Nor is Hanover Shoe an anomaly; addressing a federal damages provision mirroring that of the Cartwright Act, the Supreme Court in Adams v. Mills, supra, 286 U.S. at pages 406-408, likewise rejected the defendants’ pass-on theory. 10 This divergence illustrates not that *772 either conclusion must be wrong, only that reasonable jurists may—from a text as opaque as “damages sustained”—arrive at widely differing conclusions, and that that text is thus susceptible of being read as supporting more than one rule for measuring damages. 11 The question we face is how to measure “damages sustained,” and nothing in the Cartwright Act’s language, as enacted in 1907 or thereafter amended, resolves that question. Insofar as the text of the Cartwright Act is concerned, the question is an open one.
We reject as well a second interpretive argument pressed by Manufacturers and adopted by the Court of Appeal: that at the beginning of the 20th century there was an existing, generally understood meaning for “damages by him sustained,” and we therefore should presume the Legislature intended that meaning when it used the phrase in the Cartwright Act.
The general principle that we should assume the Legislature uses words in accordance with their commonly understood meaning is sound. In
State of California ex rel. Van de Kamp
v.
Texaco, Inc.
(1988)
That principle has no similar application here. We can discern no contemporaneous consensus with respect to the phrase “damages by him sustained.” The Cartwright Act was passed in 1907 as part of a wave of tum-of-the-century state and federal legislation intended to stem the power of monopolies and cartels. (Landry & Hombeck, One Hundred Years in the Making: The Cartwright Act in Broad Outline (2008) 17, No. 2, J. Antitrust and Unfair Competition Section of State Bar 7, 7-8; State of California ex rel. Van de *773 Kamp v. Texaco, Inc., supra, 46 Cal.3d at pp. 1154-1156; see generally Limbaugh, Historic Origins of Anti-trust Legislation (1953) 18 Mo. L.Rev. 215.) It was based in part on other recently enacted state laws aimed at the same problems. (State of California ex rel. Van de Kamp v. Texaco, Inc., at pp. 1160-1162 & fn. 14; Hibner & Cooper, The Cartwright Act at 100—A History of Complementary Antitrust Enforcement—A Celebration (2008) 17, No. 2, J. Antitrust and Unfair Competition Section of State Bar 81, 91-92.) The phrase “damages sustained” or “damages by him sustained” was routinely employed in the remedial provisions of the antitrust statutes of the time. 12 However, our review of out-of-state and federal decisions in the years preceding the Cartwright Act’s 1907 adoption discloses nothing (never mind a consensus) speaking to how the “damages by him sustained” should be measured or allocated between direct and indirect purchasers who seek to sue for antitrust loss.
Certainly the California cases relied on by Manufacturers and the Court of Appeal do not establish any consensus as to how damages were to be measured. In
De Costa v. Mass. Mining Co.
(1861)
These contract and tort cases are unhelpful on the question of how to measure the “damages sustained” in an antitrust case. They express in a variety of contexts the truism that damages are to compensate for actual loss, but this, again, begs the question before us: how to measure actual loss in the context of an intermediary-purchaser antitrust action for price fixing.
*774
Notably as well, in 1907 an antitrust claim for civil money damages was a wholly new kind of claim, part of the “dramatically enhanced sanctions imposed by the [Cartwright] Act.”
(State of California ex rel. Van de Kamp v. Texaco, Inc., supra,
More generally, we consider it implausible that the Legislature had any specific intent on the question we face. Certainly nothing in what minimal legislative history has survived from the Cartwright Act’s 1907 enactment sheds any direct light on the question. The economic theories that underlie an antitrust claim are sufficiently complex that we may safely surmise the fine points of whether enforcement by direct and indirect purchasers should be permitted or preferred, and what precise proof of passed-on costs, lost sales, and lost profits should become the grist of an antitrust trial, were not at the forefront of the Legislature’s mind when enacting what was then a pioneering law. Certainly by its choice of the generic phrases “damages by him sustained” and “injured in his business or property,” the Legislature did not presume to resolve these complex questions.
Two early Court of Appeal Cartwright Act cases relied on by Manufacturers do not lead us to a different conclusion.
Krigbaum v. Sbarbaro
(1913)
Equally unilluminating is
Overland P. Co. v. Union L. Co.
(1922)
In the absence of textual guidance, we must turn elsewhere. We thus look to the Legislature’s subsequent amendments to related parts of the Cartwright Act, and we consider as well “the object which [the Cartwright Act] seeks to achieve and the evil which it seeks to prevent . . . .”
(Judson Steel Corp. v. Workers’ Comp. Appeals Bd.
(1978)
Consideration of these sources leads us to conclude the federal
Hanover Shoe
rule
(Hanover Shoe, supra, 392
U.S. at p. 494) is most consistent with legislative intent and applies equally to state claims under the Cartwright Act. Every indication available from the Legislature demonstrates that, given a choice, it would prefer an enforcement regime in which
Hanover Shoe
is the law. In particular, the Legislature’s actions at two closely related points in time are telling: (1) in 1977, following Congress’s passage of the Hart-ScottRodino amendments to the federal Clayton Act (15 U.S.C. § 12 et seq.); and (2) in 1978, in the immediate aftermath of the United States Supreme Court’s decision in
Illinois Brick, supra,
*776 B. The Cartwright Act’s Amendment History
1. Cartwright Act amendment in response to federal legislation
a. The Hart-Scott-Rodino Act
Congress amended the Clayton Act (15 U.S.C. § 12 et seq.) by passing the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the Hart-Scott-Rodino Act). The Hart-Scott-Rodino Act authorized state attorneys general to file parens patriae suits 14 on behalf of injured consumers for violations of the Sherman Act (15 U.S.C. § 1 et seq.). (15 U.S.C. § 15c(a)(l).) Congress created the remedy out of concern that consumers, the indirect purchasers who typically bear the brunt of antitrust violations in the form of higher prices, had no existing effective redress because the small amounts of their injuries made individual suits impracticable, and consumer class actions had proven a disappointing vehicle for antitrust enforcement. (H.R.Rep. No. 94-499, 2d Sess. (1976), reprinted in 1976 U.S. Code Cong. & Admin. News, pp. 2573-2577.) The Hart-Scott-Rodino Act was designed to fill the remedial gap that “sometimes resulted] in the unjust enrichment of antitrust violators and undermine[d] the deterrent effect of the treble damage action.” (Id. at pp. 2573-2574.) The remedial provisions of the Hart-Scott-Rodino Act focused on achieving full disgorgement of all illegal antitrust profits, using fluid recovery and the cy pres doctrine if necessary, because “[t]he only alternative—retention of the profits by the adjudicated wrongdoer—is unconscionable and unacceptable.” (Id. at pp. 2585-2586; see also id. at p. 2585 [“[T]he premise of § 4D [codified at 15 U.S.C. § 15d] is that defendants should be made to disgorge all measurable profits from an antitrust violation . . . .”].)
Notably, the Hart-Scott-Rodino Act originally contained no language to address the possibility that indirect purchasers might recover damages (through their respective attorneys general) when in some instances those same damages might already have been recovered by direct purchasers under the
Hanover Shoe
rule prohibiting a pass-on defense (see
Hanover Shoe, supra,
The Hart-Scott-Rodino Act was thus of a piece with Hanover Shoe. First, consistent with the policies spelled out by the United States Supreme Court, it reflected Congress’s belief that it was better to overdeter antitrust violations than to underdeter them, as well as Congress’s desire to create a remedial framework that maximized the likelihood violators would be required to fully disgorge price-fixing profits. (See H.R.Rep. No. 94-499, supra, reprinted in 1976 U.S. Code Cong. & Admin. News, pp. 2573-2586.) Second, the Hart-Scott-Rodino Act expressly contemplated that antitrust violators might be sued by both direct and indirect purchasers, and that rather than limiting direct purchaser recoveries—by repudiating Hanover Shoe—or limiting indirect purchaser suits, the problem of duplicative recoveries could be addressed by allowing damages already paid to be offset against subsequent damages claims. (See 15 U.S.C. § 15c(a)(l).)
b. The legislative response to the Hart-Scott-Rodino Act
The Legislature moved quickly to incorporate the remedial framework of the Hart-Scott-Rodino Act into the Cartwright Act, enacting a statute that precisely tracked the federal act and authorized the Attorney General to sue for Cartwright Act violations on behalf of consumers. (§ 16760, added by *778 Stats. 1977, ch. 543, § 1, p. 1747.) 16 Notably for our purposes, the Legislature adopted as well the Hart-Scott-Rodino Act’s damages provision. (Compare § 16760, subd. (a)(1) [any award must exclude damages “which duplicate^ amounts which have been awarded for the same injury”] with 15 U.S.C. § 15c(a)(l) [same].) As we have discussed, that provision was specifically designed to account for duplicative damage awards resulting from allowing indirect purchasers to recover damages when, under the Hanover Shoe no pass-on defense rule (Hanover Shoe, supra, 392 U.S. at p. 494), direct purchasers might already have been awarded those same damages. Section 16760, subdivision (a)(1), in parallel with the corresponding provision in the Hart-Scott-Rodino Act, thus took as its premise that under the Cartwright Act direct purchasers could themselves recover overcharges that might in theory have been passed on to indirect purchasers, that is, the Hanover Shoe rule. Evidently, then, the Legislature presumed that such a rule would apply to the Cartwright Act as well.
Two additional factors suggest the Legislature took as a given the application of
Hanover Shoe’s
no pass-on defense rule to the Cartwright Act. First, we may presume that when the Legislature borrows a federal statute and enacts it into state law, it has considered and is aware of the legislative history behind that enactment.
(People
v.
Butler
(1996)
Manufacturers argue it would be absurd to conclude the Legislature that passed Assembly Bill No. 1162 (1977-1978 Reg. Sess.), strengthening consumer antitrust protections, also approved the Hanover Shoe rule, which might in a hypothetical case impair consumer recoveries. Manufacturers posit a scenario in which an intermediary purchaser (such as Pharmacies here) sues first, recovers the full measure of any overcharge under Hanover Shoe, and leaves nothing for the ultimate consumers (because § 16760’s duplicativeliability language would exclude the previous recovery from an antitrust defendant’s future liability).
We have no difficulty reconciling Assembly Bill No. 1162’s consumer-protecting provisions with tacit approval of the
Hanover Shoe
rule. In the abstract, both rules are intended to achieve the same goal: maximum deterrence and disgorgement. If the
Hanover Shoe
rule enhances enforcement and deters to some degree future antitrust violations, consumers benefit. As for the specific hypothetical, it posits a scenario in which an antitrust suit is filed, a full award is made against the defendants, and the case becomes final, all before the four-year statute of limitations expires and before the Attorney General has any opportunity to file suit. The Legislature could easily have assumed that this would be a rare scenario indeed, and that the short statute of limitations (at least in comparison with the time it takes to resolve an antitrust case), combined with the availability of devices such as joinder, interpleader, and case consolidation, would make such a scenario the exception rather than the rule. (See
Union Carbide Corp. v. Superior Court
(1984)
In short, the Legislature decided to include in its new parens patriae statute a protection against the occasional potential for double recovery that arises when indirect purchasers can sue but direct purchasers are not subject *780 to a pass-on defense, a provision created under the specific belief that Hanover Shoe would apply. From this, we may infer the Legislature approved application of Hanover Shoe to the Cartwright Act.
2. Cartwright Act amendment in response to Illinois Brick
a. The sequel to Hanover Shoe; Illinois Brick
Nine years after
Hanover Shoe, supra,
Plaintiff the State of Illinois sued concrete block manufacturers for price fixing in violation of the Sherman Act (15 U.S.C. § 1 et seq.), alleging that the manufacturers had illegally increased prices and those increases were passed on to masonry contractors, who passed them on to general contractors, who charged more in their bids to build buildings for the State of Illinois and other government entities. (Illinois Brick, supra, 431 U.S. at pp. 726-727.) Again writing for the majority, Justice White explained that the availability of a pass-on defense should be symmetric. First, allowing offensive but not defensive pass-on claims would create a risk of double recovery in those cases where both direct and indirect purchasers sued, with a defendant paying the entirety of any overcharge to the direct purchaser and some additional amount to the indirect purchaser. {Id. at pp. 730-731.) Second, the uncertainties involved in tracing overcharges and the risk of overcomplicating antitrust trials extended equally to offensive pass-on cases as to defensive pass-on cases. {Id. at pp. 731-732.) Third, Hanover Shoe “rest[ed] on the judgment that the antitrust laws will be more effectively enforced by concentrating the full recovery for the overcharge in the direct purchasers rather than by allowing every plaintiff potentially affected by the overcharge to sue only for the amount it could show was absorbed by it.” {Illinois Brick, at p. 735.) Because no exception applied that would have allowed defensive use of a pass-on theory—and because Hanover Shoe was still sound law and should not be overruled—Illinois could not use a pass-on theory offensively and, as an indirect purchaser, could recover nothing.
*781 The dissenters agreed fully that Hanover Shoe was good law, but concluded the same considerations that animated it dictated a rule allowing indirect purchaser suits. (See Illinois Brick, supra, 431 U.S. at pp. 749-750 (dis. opn. of Brennan, J.).) In Hanover Shoe, the court had chosen to run the risk of overcompensating a plaintiff rather than underdeterring antitrust violations and allowing antitrust violators to retain their ill-gotten gains. In an offensive pass-on case, there was no danger that recognizing pass-on charges would allow a defendant to escape liability; rather, allowing a pass-on claim would advance the goal of preventing wrongdoers from escaping punishment. (Illinois Brick, at pp. 752-753.) The dissenters asserted that “ ‘[t]he attempt to transform a rejection of a defense because it unduly hampers antitrust enforcement into a reason for a complete refusal to entertain the claims of a certain class of plaintiffs seems an ingenious attempt to turn the decision [in Hanover Shoe] and its underlying rationale on its head.’ ” (Id. at pp. 753-754.) The majority’s concerns about double recovery, the dissenters argued, could be addressed fully through procedural devices (joinder, inter-pleader, and the like) in instances where double recovery was a risk, without resort to the majority’s blanket ban on indirect purchaser suits. (Id. at pp. 761-764.)
b. The legislative response to Illinois Brick
Illinois Brick, supra,
Passage of the Illinois Brick repealer statute was driven by the fear that indirect purchasers might be stripped of their standing to sue under the Cartwright Act because, under the reasoning of the Illinois Brick majority, application of the Hanover Shoe rule under the Cartwright Act could be interpreted as dictating that outcome. Rejecting that reasoning, the Assembly Judiciary Committee’s summary of Assembly Bill No. 3222 (1977-1978 Reg. Sess.) cited with approval Illinois Brick's “vigorous dissent.” (Assem. Com. on Judiciary, Analysis of Assem. Bill No. 3222 (1977-1978 Reg. Sess.) as introduced Mar. 27, 1978, p. 1.) It spelled out the dissent’s critique of the majority’s bar on indirect purchaser suits and indicated that as the “dissent noted ... the implementation problems cited by the majority[ 20 ] could be addressed by the application of existing procedural requirements, e.g., mandatory joinder of the direct purchaser, interpleader, parens patriae.” (Assem. Com. on Judiciary, Analysis of Assem. Bill No. 3222 (1977-1978 Reg. Sess.) as introduced Mar. 27, 1978, pp. 1-2.) The Judiciary Committee’s analysis thus accepted that allowing indirect purchaser suits would require courts to reconcile the existence of such suits with the Hanover Shoe no pass-on defense rule, and cited with approval the Illinois Brick dissent’s proposed methods for reconciliation.
Nowhere in this or any other committee report did the Legislature suggest reconciliation could or should instead occur by repudiating
Hanover Shoe
under the Cartwright Act. Rather, the existence of the
Hanover Shoe
rule was taken as a given; the relevant debate was whether indirect purchaser suits could be accommodated in a world where
Hanover Shoe
was the law. The Legislature, like the
Illinois Brick
dissent, apparently preferred procedural devices to a blanket ban on indirect purchaser suits and passed Assembly Bill No. 3222 (1977-1978 Reg. Sess.) to clarify that that preference was part of
*783
existing Cartwright Act law. (See Assem. Com. on Judiciary, Analysis of Assem. Bill No. 3222 (1977-1978 Reg. Sess.) as introduced Mar. 27, 1978, p. 2 [measure is “declarative of existing law”].) As with the passage of Assembly Bill No. 1162 (1977-1978 Reg. Sess.) the previous year, the Legislature’s adoption of this amendment indicates acceptance of
Hanover Shoe, supra,
C. Broader Legislative Policy Considerations
In divining the Legislature’s intent, we consider as well overarching legislative goals evident from the Legislature’s adoption and amendment of the Cartwright Act over the years.
From its inception, the Cartwright Act has always been focused on the punishment of violators for the larger purpose of promoting free competition. (See Stats. 1907, ch. 530, p. 984 [the Cartwright Act is “An act to define trust and to provide for criminal penalties and civil damages, and punishment of [entities connected with trusts], and to promote free competition in commerce and all classes of business in this state”].) It is, like antitrust laws generally, about “ ‘ “ ‘the protection of
competition,
not
competitors’
” ’ ”
(Cel-Tech Communications, Inc.
v.
Los Angeles Cellular Telephone Co.
(1999)
As the Cartwright Act’s primary concern is with the elimination of restraints of trade and impairments of the free market, we can and should select the damages rule most consistent with that focus. The goal of deterring antitrust violations and concerns that a given private party may receive a windfall are not of equal weight. The Legislature’s adoption of a double damages remedy (Stats. 1907, ch. 530, § 11, p. 987), later amended to treble damages (§ 16750, subd. (a)), demonstrates as much: double and treble damages may overcompensate injured plaintiffs, but they do so in order to maximize deterrence.
These relative priorities offer useful guidance. In cases where no consumers have come forward and the choice is between allowing an antitrust *784 violator to retain the full measure of profits from its violation or requiring their disgorgement to an innocent direct or intermediary purchaser who paid those monies and was forced to cope with the violation, the Legislature surely would prefer the latter, thereby maximizing deterrence and the probability of full disgorgement. 21 To allow defendants universally to assert a pass-on defense, even in cases such as this that present no risk of duplicative recovery, would hamper enforcement by reducing incentives to sue and police antitrust violations.
As
Hanover Shoe
itself recognized, a universal pass-on defense would hamper enforcement in a second way. Allowing a pass-on defense would plunge parties and courts into minitrials attempting to trace every penny of an initial overcharge, as well as seeking to measure the further ramifications that an overcharge might have in the form of lost sales and other tertiary consequences.
(Hanover Shoe, supra, 392
U.S. at pp. 492-493.) “ ‘[T]he task of disentangling overlapping damages claims is not lightly to be imposed upon potential antitrust litigants, or upon the judicial system.’ ”
(Kansas v. UtiliCorp United Inc., supra,
Manufacturers raise one overarching policy concern of their own. They object that Pharmacies simply were not damaged by the alleged price-fixing conspiracy and the law should not countenance a rule that permits a windfall to undamaged plaintiffs.
This objection misconceives both the nature of the Hanover Shoe rule in general and its potential application here. The Hanover Shoe court recognized that a purchaser forced by a monopoly or price-fixing cartel to pay higher prices might well be injured by that antitrust violation even in instances where it appeared the purchaser could pass on some or all of that overcharge downstream to others. (Hanover Shoe, supra, 392 U.S. at p. 493, fn. 9 [“The mere fact that a price rise followed an unlawful cost increase does not show *785 that the sufferer of the cost increase was undamaged.”]; see also Kansas v. UtiliCorp United Inc., supra, 497 U.S. at pp. 208-211.) A purchaser might lose profits or sales, and perhaps market share as well, vis-a-vis another purchaser/distributor not subject to the same overcharge. Recognizing the difficulty of proving the precise amount of other forms of injury, the Hanover Shoe court selected the amount of the initial overcharge as the measure of damages, not because the initial overpayment was the only injury, but because it was the most readily measured, and because measuring damages in this way would, in the long run, best serve the various goals of antitrust law. (See Hanover Shoe, at pp. 492-494; cf. 2A Areeda et al., Antitrust Law (3d ed. 2007) f 395, p. 377 [“[T]he most commonly used measure of damages, viz., the overcharge, is an ambiguous proxy for the actual damages suffered.”].)
Some or all of the injuries identified in
Hanover Shoe, supra,
At its core, Manufacturers’ argument is that the Cartwright Act should be read to go beyond the primary consequence of the price conspiracy (the overcharge) to consider the secondary consequence of the conspiracy (the pass-on), but that it should blind itself to the tertiary consequences (lost sales, lost profits, and so on). The Court of Appeal as well implicitly accepted
Hanover Shoe's,
focus on overcharges as the measure of damages and its corresponding disregard for tertiary consequences, but rejected that case insofar as it disregarded secondary consequences (the pass-on). But these two aspects of
Hanover Shoe
go hand in hand:
Hanover Shoe
found it acceptable to ignore tertiary consequences only because it
also
disregarded secondary consequences. Put differently,
Hanover Shoe
is not a case about what constitutes injury, but about how to measure damages. That a purchaser passes on an overcharge does
not
mean it lacks for injury or damages. The
Hanover Shoe
court disregarded all tertiary damages for measurement purposes because, and only because, it also disregarded the secondary pass-on for measurement purposes. Conversely, one cannot rationally admit evidence of a pass-on, under a theory of mitigation, while also excluding evidence that the pass-on in fact failed to mitigate fully the loss occasioned by the original overcharge. (See
Hanover Shoe, supra,
392 U.S. at pp. 491-494;
B.W.I. Custom Kitchen v. Owens-Illinois, Inc., supra,
*787 D. Conclusion
The inferences we draw from the Legislature’s actions and responses to developments in federal antitrust law, as well as its actions in enacting and amending the Cartwright Act over the years, all point in the same direction: For state antitrust purposes, the Hanover Shoe rule should apply even as indirect purchasers are allowed to sue. We therefore conclude, under the Cartwright Act as under federal law, that a pass-on defense generally may not be asserted. Instead, in an antitrust price-fixing case, the presumptive measure of damages is the amount of the overcharge paid by the plaintiff.
While a pass-on defense is generally precluded, a few instances remain in which it will still be available. First,
Hanover Shoe
recognized an exception for “cost-plus” contracts
(Hanover Shoe, supra,
We need not address in detail the scope of these two exceptions, for neither applies here. Manufacturers have not sought to establish that any cost-plus contract exception would apply. Nor does it appear any wholesaler, consumer, or parens patriae suits have been filed that might pose a risk of duplicative recovery, and the statute of limitations for the period at issue has long since expired. Accordingly, the trial court erred in granting summary judgment for Manufacturers on the basis of a pass-on defense.
III. The Unfair Competition Law
In a claim closely related to their Cartwright Act claims, Pharmacies also alleged they had been injured by Manufacturers’ unfair business practices and *788 were entitled to relief under the UCL (§ 17200 et seq.). The Court of Appeal affirmed the trial court’s grant of summary judgment to Manufacturers on the UCL claims, concluding Pharmacies lacked standing and, additionally, were ineligible for any relief. We consider each ground in turn.
A. Standing
“The purpose of a standing requirement is to ensure that the courts will decide only actual controversies between parties with a sufficient interest in the subject matter of the dispute to press their case with vigor.”
(Common Cause
v.
Board of Supervisors
(1989)
While the voters clearly intended to restrict UCL standing, they just as plainly preserved standing for those who
had
had business dealings with a defendant and had lost money or property as a result of the defendant’s unfair business practices. (Prop. 64, § 1, subds. (b), (d); see § 17204.) Under that standard, Pharmacies have established standing. To distribute their pharmaceuticals, Manufacturers depend on a network of wholesalers and retailers. Pharmacies acted as retailers for Manufacturers’ drugs and thus had indirect business dealings with Manufacturers. (See
Shersher v. Superior Court
(2007)
While Manufacturers argue that ultimately Pharmacies suffered no compensable loss because they were able to mitigate fully any injury by passing on the overcharges, this argument conflates the issue of standing with the issue of the remedies to which a party may be entitled. That a party may ultimately be unable to prove a right to damages (or, here, restitution) does not demonstrate that it lacks standing to argue for its entitlement to them. (See
Southern Pac. Co.
v.
Darnell-Taenzer Co., supra,
Nothing in the text of section 17204 or Proposition 64 suggests the voters intended to provide otherwise when they remade the UCL’s standing requirements. Rather, section 17204 requires only that a party have “lost money or property,” and Pharmacies indisputably lost money when they paid an allegedly illegal overcharge. We decline Manufacturers’ invitation to turn this facially simple threshold condition into a requirement that plaintiffs prove compensable loss at the outset. 25
B. Remedies
The Court of Appeal affirmed summary judgment on a second, overlapping ground: Pharmacies were not entitled to any remedy. Pharmacies’ complaint seeks two forms of relief: restitution and an injunction. We need consider only the latter. If a party has standing under section 17204 (as Pharmacies do here), it may seek injunctive relief under section 17203. (See *790 § 17204 [authorizing without limitation “[a]ctions for relief pursuant to this chapter" to be brought by parties who satisfy the provision’s standing requirement].) Manufacturers’ papers identify no obstacle that would preclude Pharmacies from obtaining injunctive relief if they establish Manufacturers were engaged in an unfair business practice. 26
The Court of Appeal held Pharmacies were barred from seeking injunctive relief because, it concluded, they had suffered no monetary loss. To the extent this holding rests on the conclusion Pharmacies lacked standing under section 17204, it is erroneous; as discussed
ante,
Pharmacies have standing. To the extent the holding rests on the conclusion that even if Pharmacies had standing, they could not seek injunctive relief unless they could also seek restitution, it similarly is erroneous. Section 17203 makes injunctive relief “the primary form of relief available under the UCL,” while restitution is merely “ancillary.”
(In re Tobacco II Cases
(2009)
As the claim for injunctive relief is sufficient to preclude summary judgment, we need not decide, and express no opinion on, the further question whether Pharmacies may eventually be entitled to restitution.
*791 Disposition
For the foregoing reasons, we reverse the Court of Appeal’s judgment and remand for further proceedings not inconsistent with this opinion.
George, C. J., Baxter, J., Moreno, J., Ruvolo, J., * Robie, J., † and Miller, J., ‡ concurred.
Notes
All further unlabeled statutory references are to the Business and Professions Code.
Plaintiffs are James Clayworth, R.Ph., an individual, doing business as Clayworth Pharmacy and Clayworth Healthcare; Marin Apothecaries, Inc., doing business as Ross Valley Pharmacy; Golden Gate Pharmacy Services, Inc., doing business as Golden Gate Pharmacy; Pediatric Care Pharmacy, Inc.; Chimes Pharmacy, Inc.; Mark Home, R.Ph., an individual, doing business as Burton’s Pharmacy; Meyers Pharmacy, Inc.; Benson Toy, R.Ph., an individual, doing business as Marin Medical Pharmacy; Seventeen Fifty Medical Center Pharmacy, Inc.; Tony Mavrantonis, R.Ph., an individual, doing business as Jack’s Drug; Julian Potashnick, R.Ph., an individual, doing business as Leo’s Pharmacies; Jerry Shapiro, R.Ph., an individual, doing business as Uptown Drag, Co.; Tilley Apothecaries, Inc., doing business as Zweber’s Apothecary; RP Healthcare, Inc.; Rohnert Park Drags, Inc.; and JGS Pharmacies, Inc., doing business as Dollar Drugs.
Defendants are Abbott Laboratories; AstraZeneca LP; Novartis Pharmaceuticals Corporation; Allergan, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly & Company; Johnson & Johnson; Janssen Pharmaceutical Inc.; Ortho-McNeil Pharmaceutical, Inc.; Ortho Biotech, Inc.; GlaxoSmithKline PLC; Pfizer, Inc.; Hoffmann-La Roche Inc.; Aventis Pharmaceuticals, Inc.; Amgen, Inc.; Merck & Co., Inc.; Bristol-Myers Squibb Company; Wyeth; Johnson & Johnson Health Care Systems Inc., which apparently does not manufacture, market, or distribute pharmaceutical products; and Pharmaceutical Research and Manufacturers of America, a United States-based nonprofit trade association.
This motion assumed arguendo that Manufacturers had engaged in price fixing. For purposes of this appeal, we do likewise.
Justice Stewart dissented on the threshold question whether United Shoe had been shown to violate the antitrust laws and accordingly did not reach the issue of how to determine damages. (See Hanover Shoe, supra, 392 U.S. at p. 513 (dis. opn. of Stewart, J.).) The seven members of the Supreme Court to consider the pass-on defense thus were unanimous in rejecting it.
One can imagine still more remote consequences as well, such as changes in the value of a business as a going concern, or changes in buying patterns by consumers who substitute purchases of other products, with consequent positive and negative effects on the various distributors in the market. And so on, and so on.
As originally enacted, the Cartwright Act’s private damages provision read: “In addition to the criminal and civil penalties herein provided, any person who shall be injured in his business or property by any other person or corporation or association or partnership, by reason of anything forbidden or declared to be unlawful by this act, may sue therefor ... to recover twofold the damages by him sustained, and the costs of suit.” (Stats. 1907, ch. 530, § 11, p. 987.)
Title 15 United States Code section 15(a).
Section 16750, subdivision (a).
At issue was a claim under section 8 of the Interstate Commerce Act (49 U.S.C. former § 8), which created liability for “the full amount of damages sustained” because of overcharges and other violations.
Manufacturers argue that
Hanover Shoe, supra, 392
U.S. 481, is not evidence of textual ambiguity because it was not a statutory interpretation case. We disagree. The United States Supreme Court itself has indicated
Hanover Shoe
resolved “a question of statutory interpretation,” namely, the “proper construction of § 4 of the Clayton Act [15 U.S.C. § 15].”
((California
v.
ARC America Corp.
(1989)
E.g., Sherman Antitrust Act of 1890 (Act of July 2, 1890, ch. 647, § 7, 26 Stat. 209, 210) (“damages by him sustained”); 1899 Michigan Public Acts, No. 255, section 11, page 412 (“damages by him sustained”); 1907 Missouri Laws, page 380 (Mo. Rev. Stat., former § 8972) (“damages by him sustained”); 1905 Nebraska Laws, chapter 162, section 18, page 644 (“damages by him sustained”); 1898 Ohio Laws, section 11, page 146 (former Ohio Gen. Code, § 6397) (“damages by him sustained”); 1893 Oklahoma Revised Statutes, chapter 83, section 4, page 1163 (“damages sustained”); 1898 Utah Revised Statutes, title 54, section 1761, page 424 (“damages sustained”).
Nor do generic contract and tort damage cases address the significant antitrust-only policy concerns that have motivated the United States Supreme Court in its reading of the Sherman and Clayton Acts (15 U.S.C. § 1 et seq.; id., § 12 et seq.) and that must influence our reading of the Cartwright Act.
“ '“Parens patriae,” literally “parent of the country,” refers traditionally to [the] role of [the] state as sovereign and guardian of persons under legal disability HD ... HQ State attorney generals [mc] have
parens patriae
authority to bring actions on behalf of state residents for anti-trust offenses and to recover on their behalf.’ ”
(Pacific Gas & Electric Co. v. County of Stanislaus
(1997)
Bill author Representative Peter Rodino made the same point, explaining on the House floor that the Hart-Scott-Rodino Act had been specifically tailored, through Senate amendments to the bill that became new section 4C(a)(l) of the Clayton Act (15 U.S.C. § 15c(a)(l)), to allow the Hanover Shoe no pass-on defense rule to coexist hand in hand with the bill’s new parens patriae suits on behalf of indirect purchasers. (Remarks of Rep. Rodino, Debate on H.R. No. 8532, 94th Cong., 2d Sess., 122 Cong. Rec. H30878-H30879 (daily ed. Sept. 16, 1976).)
See Assembly Office of Research, third reading analysis of Assembly Bill No. 1162 (1977-1978 Reg. Sess.) as amended May 17, 1977, page 1 (“The bill is modeled directly on federal law”); Senate Committee on Judiciary, Analysis of Assembly Bill No. 1162 (1977-1978 Reg. Sess.) as amended May 17, 1977, page 2 (“This bill would enact into California law essentially the same provisions which were enacted last year by Congress and put into Federal law”). Notably, the text of section 16760 shows the Legislature shared Congress’s preference for maximizing deterrence and ensuring full disgorgement of profits generated by antitrust violations: section 16760 expressly authorizes the use of cy prés and fluid recovery to maximize distribution to those harmed, with any excess to go to the Attorney General as costs or to the state as unclaimed property, rather than reverting to the wrongdoer. (§ 16760, subd. (e)(l)-(3).)
This case is perhaps far more typical. Pharmacies, intermediary purchasers, filed suit in 2004; had any consumers sought recovery of the same amounts Pharmacies seek (i.e., recovery for the years 2000-2004), they would have had to file suit long before now, and their actions could have been consolidated or coordinated without any risk of an award in this case impairing relief in any such hypothetical other case.
At the time, federal antitrust cases were treated as “applicable”
(Chicago Title Ins. Co. v. Great Western Financial Corp.
(1968)
California was not alone in this. To date, 25 states and the District of Columbia have passed Illinois Brick repealer statutes; numerous others have interpreted existing state law to allow indirect purchaser suits. (Karon, “Your Honor, Tear Down that Illinois Brick Wall!” The National Movement Toward Indirect Purchaser Antitrust Standing and Consumer Justice (2004) 30 Wm. Mitchell L.Rev. 1351, 1361-1362.) The Cartwright Act amendment and other like Illinois Brick repealer statutes have subsequently been upheld against preemption challenges. (California v. ARC America Corp., supra, 490 U.S. at pp. 105-106.)
These implementation problems were those that would arise if indirect purchaser suits were permitted at the same time that Hanover Shoe’s bar on a pass-on defense remained in place. (See Illinois Brick, supra, 431 U.S. at pp. 737-747 (maj. opn.); id. at pp. 761-764 (dis. opn.).)
In a closely related vein, we previously have approved the use of fluid recovery funds under the Cartwright Act precisely because they might be the only way to “ensure that the policies of disgorgement or deterrence are realized” and because Cartwright Act defendants should not be “permitted to retain ill gotten gains simply because their conduct harmed large numbers of people in small amounts instead of small numbers of people in large amounts.”
(State of California v. Levi Strauss & Co.
(1986)
Indeed, the possibility that in this latter scenario Pharmacies did not lose sales as a result of the alleged price-fixing conspiracy rests on the rather unlikely proposition that cash-paying customers’ demand for drugs is wholly inelastic to price.
Manufacturers argue, and the Court of Appeal agreed, that Pharmacies waived these other forms of injury. The record does not support this claim. Pharmacies expressly did not concede that they had suffered no other injuries as a result of the alleged price-fixing conspiracy. Rather, they waived any attempt to prove other injuries because those injuries’ existence and measure were legally irrelevant under
Hanover Shoe,
the rule Pharmacies contended applied under the Cartwright Act. As we agree that
Hanover Shoe
applies, we need not consider whether, had we concluded it did not, Pharmacies should have been permitted to prove injuries other than the overcharge in this case. (Cf.
B.W.I. Custom Kitchen v. Owens-Illinois, Inc., supra,
We are aware of no statute or case that adopts such an in-between rule, and Manufacturers have cited none. The irrationality of such a rule is inferable as well from the United States Supreme Court’s own precedents. To prevail on a pass-on defense in those rare instances where it has been permitted under federal law, a defendant must show the plaintiff could not have raised rates otherwise
(Kansas v. UtiliCorp United Inc., supra,
*787 secondary consequences) is only presentable in circumstances that foreclose the possibility of tertiary consequences (lost sales and profits). Only then can one fairly say in defense that the plaintiff has suffered no injury as the result of an illegal overcharge.
In contrast, in stable markup cases such as this one, where a purchaser’s resale price is fixed as a direct function of its acquisition price so as to pass on any overcharge, the resale market’s response to that overcharge-inflated resale price is not fixed and may be different than it would have been in the absence of the overcharge—and that different response (e.g., lower sales) may injure the plaintiff.
Doing so would render the UCL’s standing requirement substantially more stringent than other state unfair competition statutes such as the Cartwright Act, under which Pharmacies’ standing is undisputed. Again, we see nothing in the text or history of Proposition 64 that suggests the voters intended such a result.
In this court, Manufacturers argue that Pharmacies have waived reliance on their complaint’s request for injunctive relief to defeat summary adjudication. This argument misplaces the relevant burden. If Manufacturers sought summary judgment on the ground Pharmacies could obtain no relief on their UCL claim, it was incumbent on Manufacturers, as the moving party, to show that each form of relief sought by Pharmacies was unavailable. While Manufacturers attempted that showing with respect to the request for restitution, their moving papers simply ignored Pharmacies’ request for injunctive relief.
In any event, the issue whether the availability of injunctive relief bars summary adjudication was decided by the Court of Appeal and folly briefed before us by the parties. It involves a pure issue of law, reviewable de novo. We may exercise our discretion to consider it. (See
People v. Superior Court (Laff)
(2001)
Presiding Justice of the Court of Appeal, First Appellate District, Division Four, assigned by the Chief Justice pursuant to article VI, section 6 of the California Constitution.
Associate Justice of the Court of Appeal, Third Appellate District, assigned by the Chief Justice pursuant to article VI, section 6 of the California Constitution.
Associate Justice of the Court of Appeal, Fourth Appellate District, Division Two, assigned by the Chief Justice pursuant to article VI, section 6 of the California Constitution.
